|Bid||16.65 x 1200|
|Ask||16.81 x 800|
|Day's Range||16.56 - 17.34|
|52 Week Range||14.33 - 36.95|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Crinetics Pharmaceuticals (CRNX) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Crinetics Pharmaceuticals, Inc. (CRNX) delivered earnings and revenue surprises of -13.33% and -100.00%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. Active...